Pleural Effusions

Another interesting study entitled "Phase studies of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small cell lung cancer" by LL Herscher, SM Hahn, Kroog G, H Pass, B Temeck, Goldspiel B, J Cook, JB Mitchell and J Liebmann

Another interesting study entitled "Phase studies of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small cell lung cancer" by LL Herscher, SM Hahn, Kroog G, H Pass, B Temeck, Goldspiel B, J Cook, JB Mitchell and J Liebmann

Another interesting study entitled "Phase studies of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small cell lung cancer" by LL Herscher, SM Hahn, Kroog G, H Pass, B Temeck, Goldspiel B, J Cook, JB Mitchell and J Liebmann

Another interesting study entitled "Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma" J Mezger, R and W Lamerz Permanetter - Department of Internal Medicine III, Klinikum Grosshadern, Munich, Federal Republic of Germany. . Journal of Thoracic and Cardiovascular Surgery, Vol 100, 860-866 Here is an excerpt, "histologic and cytologic distinction of malignant mesothelioma cancer metastases in the pleura or peritoneum is often problematic because of immunological method. Increasingly used as diagnostic adjuncts. U this review summarizes 40 studies on carcinoembryonic antigen expression in mesotheliomas and lung and other cancers, including the pleura or peritoneum. carcinoembryonic antigen was identified immunohistochemically in 11% of mesotheliomas and 84% of cancers examined and immunocytochemically (in serous effusion) in 4% and 58%, respectively . in serum and pleural or ascitic fluid, significantly elevated levels of carcinoembryonic antigen are often associated with (lung) cancer, but rarely with mesotheliomas. So, together with the identification of antigens in serum, pleural fluid, or ascitic fluid, immunohistochemical and immunocytochemical techniques for detecting carcinoembryonic antigen to provide valuable help to distinguish malignant mesothelioma from metastatic carcinoma ."

We all owe debt of gratitude to these fine researchers. If you find any of these statements interesting, please read the study in its entirety.